1. India Stocks

  2. •

    Industrials

  3. •

    Specialty Business Services
Sai Life Sciences Limited

Sai Life Sciences Limited

SAILIFE.NS
Sai Life Sciences LimitedIN flagNational Stock Exchange of India
1,237.00
INR
+4.40
- -
262.60BMarket Cap

Total Valuation

Sai Life Sciences Limited carries a market capitalization of 262.60B, placing it among publicly traded companies globally. Its enterprise value stands at 155.47B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap262.60B
Enterprise Value155.47B

Valuation Ratios

Sai Life Sciences Limited trades at a trailing price-to-earnings ratio of 63.69.

PE Ratio63.69
PS Ratio8.15
PB RatioN/A
P/TBV RatioN/A
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Sai Life Sciences Limited trades at an EV/EBITDA multiple of 43.47 and an EV/FCF ratio of 308.99. The EV/Sales ratio of 8.15 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 43.47 provides insight into valuation relative to core operating earnings.

EV / Sales8.15
EV / EBITDA43.47
EV / EBIT43.47
EV / FCF308.99

Financial Position

Sai Life Sciences Limited maintains a current ratio of 3.28, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 111.45, indicating elevated leverage, while an interest coverage ratio of 5.31 demonstrates adequate ability to service its debt obligations.

Current Ratio3.28
Quick Ratio0.76
Debt / Equity111.45
Debt / EBITDAN/A
Interest Coverage5.31

Financial Efficiency

Return on Equity (ROE)25.85
Return on Assets (ROA)6.26
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)17.25
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover10.02

Taxes

Over the trailing twelve months, Sai Life Sciences Limited has paid 824.31M in income taxes, reflecting an effective tax rate of 25.25.

Income Tax824.31M
Effective Tax Rate25.25

Stock Price Statistics

Sai Life Sciences Limited's stock has gained approximately 55.86216% over the past 52 weeks. The 50-day moving average sits at 1,154.69, while the 200-day moving average is 975.77.

Beta (5Y)N/A
52-Week Price Change55.86216%
50-Day Moving Average1,154.69
200-Day Moving Average975.77
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Sai Life Sciences Limited generated 19.08B in revenue and converted that into 2.44B in net income, yielding earnings per share of 11.88. EBITDA reached 3.58B, while operating income came in at 3.58B.

Revenue19.08B
Gross Profit7.76B
Operating Income3.58B
Pretax Income3.27B
Net Income2.44B
EBITDA3.58B
EBIT3.58B
Earnings Per Share (EPS)11.88

Margins

Sai Life Sciences Limited operates with a gross margin of 40.68, reflecting its pricing power and cost economics. The operating margin of 18.75 and net profit margin of 12.79 provide insight into operational efficiency.

Gross Margin40.68
Operating Margin18.75
Pretax Margin17.12
Profit Margin12.79
EBITDA Margin18.75

Scores

Sai Life Sciences Limited posts an Altman Z-Score of 12.00, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score12.00